Antibodies to CD23, derivatives thereof, and their therapeutic uses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 7, 2006
Grant Date -
N/A
app pub date -
May 7, 1999
filing date -
May 9, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to antibodies which bind to the CD23 (FCεRII) type II molecule particularly altered antibodies including antibodies which bind to the CD23 (FCεRII) type II molecule characterized by an affinity constant equal to or greater than 1×109 Ka Mol-1, the preparation of such antibodies, pharmaceutical compositions which contain such antibodies and their use in therapy particularly in the treatment of autoimmune and inflammatory disorders.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully